SCHEMBL3519210

SCHEMBL3519210

COc1ccc(-c2ccnc(Nc3ccc(C)c(S(N)(=O)=O)c3)n2)cc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTOR P42345 4/20 0.59
IKBKB O14920 5/20 0.53
CDK2 P24941 7/20 0.49
PIK3CA P42336 5/20 0.49
PIK3CG P48736 5/20 0.49
CDK1 P06493 4/20 0.49
CDK4 P11802 1/20 0.48
GSK3B P49841 2/20 0.48
DKK1 O94907 1/20 0.48
SMG1 Q96Q15 1/20 0.46
MAPK8 P45983 2/20 0.46
MAPK10 P53779 1/20 0.46
BTK Q06187 1/20 0.46
JAK2 O60674 3/20 0.46
FLT3 P36888 2/20 0.46
EGFR P00533 3/20 0.45
PTK2B Q14289 2/20 0.45
PRKCG P05129 2/20 0.45
LCK P06239 2/20 0.45
PLK4 O00444 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3518659 0.91 IKBKB (0.52) MTORIKBKBCDK2PIK3CAPIK3CG
SCHEMBL3519335 0.90 IKBKB (0.51) MTORIKBKBCDK2PIK3CAPIK3CG
SCHEMBL3520083 0.84 IKBKB (0.61) MTORIKBKBCDK2PIK3CAPIK3CG
SCHEMBL4883123 0.83 CAMKK2 (0.52) IKBKBCDK2PIK3CAPIK3CGCDK4
SCHEMBL3524407 0.80 IKBKB (0.71) IKBKBGSK3BDKK1SMG1MAPK8
SCHEMBL3521925 0.80 IKBKB (0.71) IKBKBCDK2CDK4GSK3BDKK1
SCHEMBL3516749 0.78 IKBKB (0.51) IKBKBCDK2PIK3CAPIK3CGCDK1
SCHEMBL12801092 0.76 CDK5 (0.71) PIK3CAPIK3CGGSK3BJAK2FLT3
SCHEMBL4897612 0.76 JAK2 (0.56) IKBKBCDK2PIK3CAPIK3CGCDK4
SCHEMBL14254202 0.76 JAK2 (0.53) IKBKBCDK2PIK3CAPIK3CGJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799915-B2 Anilino-pyrimidine analogs WYETH LLC (US) 2010-09-21 US claimed
EP-1799652-A1 N-BENZENESULFONYL SUBSTITUTED ANILINO-PYRIMIDINE ANALOGS Wyeth (US) 2007-06-27 EP claimed
WO-2006044457-A1 N-BENZENESULFONYL SUBSTITUTED ANILINO-PYRIMIDINE ANALOGS WYETH (US) 2006-04-27 WO claimed
US-20060079543-A1 Anilino-pyrimidine analogs WYETH (US) 2006-04-13 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060079543-A1 Anilino-pyrimidine analogs DPYD, TYMP, ADORA3 MTOR 2111/4885IKBKB 3246/4885CDK2 11/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.